Publications by authors named "Mike Becquet"

Claim this Profile
C
Continuous low-dose infusion of patupilone increases the therapeutic index in mouse and rat tumour models.
Mike Becquet, Laurent Laborde, Celine Texier, Dario Sterker, Hans-Peter Gschwind

Anticancer Drugs· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Angiogenic/Vascular Effects of the mTOR Inhibitor Everolimus Are Not Detectable by FDG/FLT-PET.
Michael Honer, Thomas Ebenhan, Peter R Allegrini, Simon M Ametamey, Mike Becquet

Transl Oncol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor interstitial fluid pressure as an early-response marker for anticancer therapeutics.
Stephane Ferretti, Peter R Allegrini, Mike M Becquet, Paul Mj McSheehy

Neoplasia· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo.
Markus Rudin, Paul M J McSheehy, Peter R Allegrini, Martin Rausch, Diana Baumann, Mike Becquet

NMR Biomed· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis